Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Tempur Sealy (TPX), GrubHub (GRUB), United States Steel Corporation (X) Among Top Weekly Gainers

Page 1 of 2

It was a mixed week for the market last week, as the Dow gave up 0.75% of its value, while the S&P 500 was down slightly, and the Nasdaq was 1.21% in the green. Positive earnings releases from Apple Inc. (NASDAQ:AAPL), Alphabet Inc (NASDAQ:GOOGL), Facebook Inc (NASDAQ:FB), and Amazon.com, Inc. (NASDAQ:AMZN) during the past week helped push the Nasdaq higher, while broader economic uncertainty and The Fed’s decision to leave interest rates unchanged for at least the next two months dragged down the other two indexes.

While the aforementioned tech stocks all enjoyed strong showings last week, they were greatly outdone by several stocks, including GrubHub Inc (NYSE:GRUB), Evoke Pharma Inc (NASDAQ:EVOK), Tempur Sealy International Inc (NYSE:TPX), Alimera Sciences Inc. (NASDAQ:ALIM), and United States Steel Corporation (NYSE:X). Let’s check out how these stocks performed last week and what led to those glowing performances. Let’s also take a peek at hedge fund ownership data to see how top investors have been playing these stocks in recent months.

Through extensive research that covered the portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).

sleep, mattress, woman, bed, bedding, cloud, comfortable, dream, soft, nightwear, girl, pillow, young, 20s, gorgeous, imagining, expression, clothes, adult, napping,

Ljupco Smokovski/Shutterstock.com

Evoke Pharma Rebounds on FDA Decision

Evoke Pharma Inc (NASDAQ:EVOK) was white-hot on Thursday, gaining 47.8% after it was revealed that the FDA had conditionally accepted the company’s Gimoti brand name for its metoclopramide nasal spray EVK-001. For the week, shares gained 62.9%, which has taken some of the sting out of their cataclysmic 73% loss on July 18 after that same EVK-001 missed its primary endpoints in a phase 3 study for the treatment of diabetic gastroparesis in female patients.

With the FDA having now conditionally accepted the Gimoti name, Evoke Pharma President and CEO Dave Gonyer, R.Ph., believes that it is still worth seeking approval for the drug. The company plans to undertake further phase 3 studies, believing the results from the failed study to be “an anomaly”.

Three hedge funds in our database were shareholders of Evoke Pharma Inc (NASDAQ:EVOK) on March 31, owning 3.40% of its float.

Follow Evoke Pharma Inc (NASDAQ:EVOK)
Trade (NASDAQ:EVOK) Now!

GrubHub Jumps on Record Results

It was also a big Thursday that propelled GrubHub Inc (NYSE:GRUB) to a strong week, in which it gained 19.41%. The online restaurant marketplace operator easily topped estimates with its second quarter financial results released on Thursday morning, as active diners jumped by 24% during the quarter to a record 7.35 million. Revenue came in at $120.2 million, with non-GAAP EPS coming in at $0.23. Estimates had predicted revenue of $114.2 million and EPS of $0.19. The company’s third quarter revenue guidance also topped estimates of $113.9 million, checking in at $116 million-to-$119 million. The company cited improvements made to its ratings and review system for its improved performance.

Ross Turner‘s Pelham Capital was one of 23 hedge funds in our database that were long GrubHub Inc (NYSE:GRUB) on March 31, owning 5.77 million shares of the stock.

Follow Grubhub Inc. (NYSE:GRUB)
Trade (NYSE:GRUB) Now!

We’ll check out the performance of three other top weekly gainers on the next page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!